Page last updated: 2024-11-03

proadifen and Cancer of Pituitary

proadifen has been researched along with Cancer of Pituitary in 1 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luini, AG1
Axelrod, J1

Other Studies

1 other study available for proadifen and Cancer of Pituitary

ArticleYear
Inhibitors of the cytochrome P-450 enzymes block the secretagogue-induced release of corticotropin in mouse pituitary tumor cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1985, Volume: 82, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acid

1985